WuXi Biologics Repeats on CDP Supplier Engagement A List
Event summary
- WuXi Biologics named to CDP Supplier Engagement Assessment A List for the second consecutive year in 2026.
- Company recognized for leadership in engaging suppliers on climate-related issues, including governance, target-setting, and Scope 3 emissions disclosure.
- WuXi Biologics committed to achieving net-zero emissions across the value chain by 2050, with SBTi-approved targets.
- Over 13,000 employees support 982 integrated client projects, with complex modalities representing more than half of the portfolio.
The big picture
WuXi Biologics' repeated inclusion on the CDP Supplier Engagement A List underscores its strategic focus on sustainability and supply chain transparency. As the biopharmaceutical industry faces increasing pressure to reduce environmental impact, WuXi Biologics' commitment to net-zero emissions and strong ESG practices positions it as a leader in the CRDMO sector. The company's ability to engage suppliers effectively and drive continuous improvement will be critical in maintaining its competitive edge.
What we're watching
- Sustainability Leadership
- How WuXi Biologics will maintain its position as a global leader in Green CRDMO amid increasing competition.
- Supply Chain Engagement
- The pace at which WuXi Biologics can drive continuous improvement across its value chain through supplier collaboration.
- Regulatory Compliance
- Whether WuXi Biologics can sustain its strong performance in ESG ratings and certifications from multiple global agencies.
Related topics